Jean-Marc Regimbeau
Jean-Marc Regimbeau is an expert in Surgery at Centre Hospitalier Universitaire Amiens-Picardie (France). As of October 2026, ScienceLeadR ranks Jean-Marc Regimbeau in the top 1% of experts worldwide for Endoscopy, Peritonitis and Gallbladder Diseases. Jean-Marc Regimbeau has authored 741 publications, the most recent in 2026, and is an investigator in 61 clinical trials, 16 of them ongoing. SLR score: 2,776 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Gastroenterology - Oncology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2026
Number : 741
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Management of sigmoid diverticular abscess by surgeons and gastroenterologists: a French survey. PMID 42635713 — abscess, drainage, colon, sigmoid, diverticulitis, therapeutics, general surgery, gastroenterologists, surgeons | Updates Surg | 2026 | 0 |
| Preoperative High-Dose Corticosteroids in Digestive Cancer Surgery: A Randomized Clinical Trial. PMID 42616512 — methylprednisolone, intraabdominal infections, surgical procedures, operative, adrenal cortex hormones, neoplasms, wound infection, infections, postoperative complications | JAMA Surg | 2026 | 1 |
| Should robotic cholecystectomy not be recommended? PMID 42557138 — cholecystectomy, general surgery | J Visc Surg | 2026 | 0 |
| Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma? PMID 42496491 — mortality, lymph node excision, neoplasms, liver, general surgery, cholangiocarcinoma, intrahepatic cholangiocarcinoma | World J Surg | 2026 | 0 |
| Impact of postoperative chemotherapy in patients resected for esophagogastric adenocarcinoma with major pathological response after preoperative chemotherapy: a study from the FREGAT database. PMID 42466102 — neoplasms, adenocarcinoma, drug therapy, chemotherapy | Ther Adv Med Oncol | 2026 | 0 |
Clinical Studies 61
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 24
Ongoing Clinical Trials
16 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| metastatic colorectal cancer 2023-504831-42-00 — neoplasms, drug therapy, liver, neoplasm metastasis, therapeutics, colorectal neoplasms, chemotherapy | Phase 3 | Recruiting | 2025 |
| An Evaluation of Multisense to Ensure a Safe Return Home Following High risk Gastrointestinal Surgery Compared With Standard Care NCT07552805 — monitoring, ambulatory, solutions, physicians, length of stay | N/A | Recruiting | 2026 |
| Superior Mesenteric Artery First Versus Standard Approach in Pancreaticoduodenectomy NCT07547033 — surgical oncology, pancreaticoduodenectomy, neoplasms, adenocarcinoma, mesenteric artery, superior, arteries, pancreas, mesenteric arteries, gestures, dissection, surgeons, head | N/A | Not yet recruiting | 2026 |
| CRP Point of care Testing Trajectory a Predictive Factor for Anastomotic Leak in Elective Colorectal Surgery NCT07464600 — research design, blood, point-of-care systems, blood specimen collection, rehabilitation, recycling, anastomotic leak, point-of-care testing, colorectal surgery | N/A | Recruiting | 2025 |
| Surgical treatment of large incisional hernia with botulinum toxin A injection a double blind randomized controlled trial 2023-504554-35-00 — hernia, injections, botulinum toxins, type a, botulinum toxins, therapeutics, incisional hernia | Phase 3 | Recruiting | 2025 |
LeadR Networks
Main global connection map